S&P 500 Healthcare Sector SEC Filings — April 27, 2026

27-04-2026

Peoples Financial Corporation held its 2026 Annual Meeting of Shareholders on April 22, 2026, with 4,335,240 shares represented out of 4,617,466 outstanding, achieving quorum. All six board-nominated directors were elected under plurality voting despite significant withheld votes averaging ~37% for each nominee, while the opposition nominee Stewart F. Peck received ~39% support but did not prevail. Shareholders strongly ratified EisnerAmper LLP as auditors (~98% for), but the advisory vote on executive compensation passed narrowly with ~61% approval amid ~37% opposition.

• ·Proposal 2 votes: 4,228,850 For, 7,584 Against, 98,806 Abstain
• ·Proposal 3 votes: 2,649,976 For, 1,621,715 Against, 63,549 Abstain
• ·Director votes - Ronald G. Barnes: 2,750,360 For, 1,583,979 Withheld
• ·Director votes - Padrick D. Dennis: 2,757,360 For, 1,576,975 Withheld
• ·Director votes - Jeffrey H. O'Keefe: 2,760,036 For, 1,574,379 Withheld
• ·Director votes - Katherine Paige Hunt: 2,747,055 For, 1,587,280 Withheld
• ·Director votes - George J. Sliman, III: 2,748,359 For, 1,585,856 Withheld
• ·Director votes - Chevis C. Swetman: 2,677,636 For, 1,656,476 Withheld
• ·Opposition nominee Stewart F. Peck: 1,661,993 For, 2,602,505 Withheld

27-04-2026

New ERA Energy & Digital, Inc. prepaid and satisfied its $50 million senior secured convertible promissory note to SharonAI, Inc., paying the full principal plus accrued interest in cash on April 24, 2026, following an irrevocable prepayment notice on April 10, 2026. SharonAI did not elect to convert any portion of the note. This clears all remaining payment obligations related to the company's acquisition of Texas Critical Data Centers LLC.

• ·Prepayment notice delivered to SharonAI on April 10, 2026.
• ·Payment and satisfaction of note occurred on April 24, 2026.
• ·Company trades as NUAI (Common Stock) and NUAIW (Warrants) on Nasdaq.

27-04-2026

HBT Financial reported Q1 2026 GAAP net income of $11.2 million ($0.34 per diluted share), down from $18.9 million ($0.60/share) in Q4 2025 and $19.1 million ($0.60/share) in Q1 2025, primarily due to $15.7 million in nonrecurring acquisition-related expenses from the CNB merger completed March 1, 2026. Adjusted net income improved to $22.6 million ($0.68/share), up from $20.1 million in Q4 2025 and $19.3 million in Q1 2025, supported by net interest income growth of 11.6% QoQ to $56.4 million and NIM expansion of 8 bps to 4.20%; however, noninterest expense surged 58.6% QoQ to $52.4 million and tangible book value per share declined 1.1% QoQ to $17.01. The merger added $1.8 billion assets, $1.3 billion loans, and $1.5 billion deposits, but organic loans decreased $65.6 million QoQ and nonperforming assets rose to 0.21% of total assets.

• ·Negative provision for credit losses of $0.2 million in Q1 2026.
• ·Net charge-offs flat at $0.8 million QoQ.
• ·Allowance for credit losses 1.29% of loans and 457% of nonperforming loans at Mar 31 2026.
• ·$85.0 million subordinated notes issued as Tier 2 capital.
• ·$14.4 million remaining under stock repurchase program as of Mar 31 2026.

27-04-2026

Green Thumb Industries Inc. (GTBIF) filed its DEF 14A proxy statement dated April 27, 2026, for the virtual annual and special shareholder meeting on June 16, 2026, at 2:00 p.m. CT, covering proposals to set the board at seven directors, elect directors, advisory approval of named executive officer compensation, re-appoint Baker Tilly US, LLP as auditors, and amend articles to modify automatic conversion of Super Voting Shares. The record date is April 20, 2026; no specific financial metrics or period-over-period comparisons are detailed in the provided filing excerpt, which focuses on governance and voting logistics.

• ·Voting deadline: 10:59 p.m. CT on June 12, 2026, or 48 hours before any adjournment.
• ·Post-meeting reception at Garcia’s Chicago (1001 W Washington Blvd, Chicago, IL 60607) at 3:30 p.m. CT on June 16, 2026.
• ·Proxy materials available at investors.gtigrows.com/2026proxy and 2026 Annual Report (including 10-K for year ended December 31, 2025) at investors.gtigrows.com/2026annualreport.

27-04-2026

Financial Plan, Inc. filed its 13F-HR report on April 27, 2026, disclosing 94 equity holdings as of March 31, 2026, with a total market value of $932938470. The portfolio features heavy allocations to ETFs such as American Century ETF TR US EQT ETF ($154980210) and Dimensional ETF Trust US Core Equity 2 ($137437794), alongside positions in stocks like Apple Inc. ($5704514) and Microsoft Corp. ($4512192). No prior period data is provided for comparisons.

• ·Filing CIK: 0002107584
• ·State of Incorporation: WA
• ·Business Address: 11 Bellwether Way, Suite 301, Bellingham WA 98225
• ·Phone: 360-714-1234
• ·SEC File Number: 028-25994

27-04-2026

Cintas Corporation (CTAS) entered into a merger agreement on March 10, 2026, to acquire UniFirst Corporation (UNF) through a two-step merger process, with UniFirst shareholders receiving $155.00 in cash and 0.7720 shares of Cintas common stock per UniFirst share. Cintas expects to issue approximately 14,261,683 shares, resulting in UniFirst shareholders owning 3.4% of the combined company post-merger, while current Cintas shareholders retain 96.6%. The UniFirst board unanimously recommends approval, supported by a voting agreement from the Croatti family controlling approximately two-thirds of UniFirst's voting power; a special shareholder meeting is scheduled for [•], 2026.

• ·UniFirst common stock trades on NYSE under symbol 'UNF'; Cintas common stock trades on NASDAQ under 'CTAS'.
• ·UniFirst special meeting to be held virtually on [•], 2026, at 10:00 a.m. ET; record date [•], 2026.
• ·Merger requires two-thirds approval of combined voting power of UniFirst shares; no appraisal rights for shareholders.
• ·UniFirst will delist from NYSE and deregister under Exchange Act post-merger.

27-04-2026

On April 24, 2026, Medtronic plc disclosed that an unauthorized third party accessed data in certain of its IT systems, prompting the company to contain the incident, activate response protocols, and engage external cybersecurity experts. To date, no impacts have been identified on products, patient safety, customer connections, manufacturing, distribution, financial reporting, or ability to meet patient needs. The company does not expect a material impact on its business or financial results, though forward-looking risks include potential data misuse, litigation, reputational harm, and regulatory scrutiny.

• ·Statement issued on company website as Exhibit 99.1
• ·Information under Item 7.01 not deemed 'filed' or incorporated by reference
• ·Numerous senior notes listed on NYSE (e.g., 1.125% due 2027 as MDT/27, up to 4.150% due 2053 as MDT/53)

27-04-2026

Brown Financial Advisory filed its 13F-HR report for the quarter ended March 31, 2026, disclosing 49 equity holdings with a total market value of $201644295, all held with sole voting and dispositive power. The portfolio is diversified across individual stocks such as Apple Inc (1258040 value), Microsoft Corp (1210985 value), and Amazon.com Inc (526507 value), and various ETFs from providers like SPDR, Vanguard, and iShares. No changes or performance metrics were reported in this static holdings disclosure.

• ·Filing signed by Joshua Wyatt Lancaster on April 24, 2026
• ·Business address: 54 S. Greeno Road, Fairhope, AL 36532
• ·All holdings reported with sole voting power (SH SOLE) and no put/call options

27-04-2026

New Peoples Bankshares Inc (NWPP) filed an 8-K on April 27, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), likely disclosing Q1 2026 financial results. The filing, sized at 3 MB, includes attached exhibits but no specific monetary figures or performance metrics are available in the provided metadata. No period-over-period comparisons or segment details are evident.

27-04-2026

Lakeland Financial Corporation filed an 8-K on April 27, 2026, under Items 7.01 and 9.01, disclosing a 2026 Q1 Investor Presentation (Exhibit 99.1) for use by executive officers in meetings with investors and analysts. The presentation and Item 7.01 are not deemed 'filed' under the Securities Exchange Act of 1934 or incorporated into other filings. Signed by Lisa M. O’Neill, EVP and CFO.

27-04-2026

Commercial Vehicle Group, Inc. (CVGI) filed its DEF 14A Proxy Statement on April 27, 2026, for the virtual Annual Meeting of Stockholders on May 14, 2026, seeking election of seven director nominees, approval of the Second Amended and Restated 2020 Equity Incentive Plan, an advisory vote to approve named executive officer compensation, and ratification of KPMG LLP as independent auditor for the fiscal year ending December 31, 2026. The statement includes executive compensation disclosures referencing Principal Executive Officers (PEOs) James R. Ray (2023-2025), Robert R. Griffin, and Harold Bevis (2021-2022). Record date is March 16, 2026.

• ·Virtual Annual Meeting: May 14, 2026, at 1:00 p.m. Eastern Time via www.virtualshareholdermeeting.com/CVGI2026 (16-digit control number required)
• ·Record Date: March 16, 2026
• ·Fiscal year references: 2025 (Jan 1 - Dec 31, 2025), 2024, 2023, 2022, 2021

27-04-2026

Sagimet Biosciences highlighted strong Phase 3 acne data from partner Ascletis, where denifanstat met all primary and secondary endpoints including 33.2% IGA treatment success (vs 14.6% placebo) and -57.4% total lesion reduction (vs -35.4%), with NDA accepted by China NMPA in December 2025; Sagimet plans US Phase 3 initiation in 2H 2026. Cash position stood at $113.1M as of 12/31/2025 but declined to $104.5M as of 3/31/2026 amid ongoing Phase 1 for TVB-3567. Further MASH development is paused pending non-dilutive funding.

• ·Denifanstat composition of matter patent expires 2032 (potential PTE to 2037)
• ·TVB-3567 composition of matter patent expires 2035 (potential PTE to 2038); acne method of use to 2046
• ·Denifanstat + resmetirom patent application to 2044 (potential PTE to 2048)
• ·Phase 1 results for TVB-3567 anticipated 2026; Phase 2 POC in 2H 2026
• ·MASH Phase 2b met primary histology endpoint with fibrosis reduction; FDA Breakthrough Therapy designation
• ·Global acne market expected to reach $20B by 2034

27-04-2026

OceanFirst Financial Corp. and Flushing Financial Corporation announced that the Federal Reserve Board granted approval for their merger on April 24, 2026, following approvals from the New York State Department of Financial Services on March 23, 2026, and the Office of the Comptroller of the Currency on April 6, 2026. No further regulatory approvals are required, and the transaction is expected to close no later than June 1, 2026, subject to remaining closing conditions. OceanFirst also announced its 2026 Annual Meeting of Stockholders will be held virtually on May 27, 2026.

• ·Merger Agreement dated December 29, 2025
• ·Annual Meeting record date: April 2, 2026
• ·Proposed Warburg Pincus investment in OceanFirst equity securities

27-04-2026

News Corporation disclosed via 8-K the provision of information to the Australian Securities Exchange (ASX) on April 24, 2026, related to its ongoing $1 billion stock repurchase program authorizing purchases of Class A and Class B common stock. Exhibits 99.1 and 99.2 contain the specific ASX disclosures, which include forward-looking statements on repurchase intentions subject to market conditions and other factors. No specific repurchase transactions were detailed in the filing.

• ·Filing reports event date of April 24, 2026
• ·Securities: Class A Common Stock (NWSA), Class B Common Stock (NWS) on Nasdaq Global Select Market

27-04-2026

Flushing Financial Corporation announced on April 27, 2026, that it has received all necessary regulatory approvals for its merger with OceanFirst Financial Corp., including Federal Reserve approval on April 24, 2026, New York State Department of Financial Services approval on March 23, 2026, and Office of the Comptroller of the Currency approval on April 6, 2026. No further regulatory approvals are required, and the transaction is anticipated to close no later than June 1, 2026, subject to satisfaction or waiver of remaining closing conditions under the Merger Agreement dated December 29, 2025. A joint press release is attached as Exhibit 99.1.

• ·Merger involves combination of Flushing and OceanFirst as well as their bank subsidiaries
• ·Filing incorporates joint press release as Exhibit 99.1

27-04-2026

Trademark Financial Management, LLC filed its 13F-HR report on April 27, 2026, for the quarter ended March 31, 2026, disclosing 102 equity positions with a total market value of $204,142,961, all held with sole voting and investment discretion. Largest holdings include iShares Core S&P 500 ETF at $23,664,081, Putnam ETF Trust Focused Large Cap at $11,333,896, J.P. Morgan Core Plus Bond ETF at $10,792,791, and Dimensional ETF Trust International Value at $10,453,697. No short positions, puts, or calls were reported.

• ·Individual stock holdings include Amazon.com Inc ($868,486, 4,170 shares), Apple Inc ($619,701, 2,442 shares), Microsoft Corp ($1,793,650, 4,845 shares), Nvidia Corp ($551,453, 3,162 shares), and Costco Wholesale Corp ($775,627, 778 shares).
• ·All positions reported as SH SOLE with zero put or call options.

27-04-2026

Financial Planning Fort Collins, LLC filed its 13F-HR report on April 27, 2026, disclosing 33 equity holdings as of March 31, 2026, primarily consisting of individual stocks and ETFs with sole ownership. Key positions include SPDR funds, NVIDIA Corporation (combined market value over $29M across shares and puts), Vanguard index funds, and iShares ETFs. No period-over-period changes or performance metrics are provided in the filing.

• ·All positions reported as SOLE ownership with zero shared, other, or performance rights.
• ·Portfolio address: 375 Horsetooth Rd, Bldg 3 Ste 203, Fort Collins, CO 80525-3197.
• ·Contact: Rita Rhodes, phone 815-900-2202, Rockford, IL.

27-04-2026

COCA-COLA EUROPACIFIC PARTNERS plc (CCEP) disclosed purchases of a total 1,291,910 ordinary shares between April 20-24, 2026, as part of its share buyback program. Transactions occurred on US Trading Venues (1,290,670 shares) and London Stock Exchange (1,240 shares), with volume weighted average prices ranging from USD 96.4203 to USD 97.9672 and GBP 72.8219. No period-over-period comparisons or performance metrics were provided.

• ·VWAP: USD 97.9672 (20 Apr US), GBP 72.8219 (20 Apr LSE), USD 96.4203 (21 Apr US), USD 96.5019 (22 Apr US), USD 96.9748 (23 Apr US), USD 97.9083 (24 Apr US)
• ·Trading venues: Primarily US Trading Venues; one transaction on London Stock Exchange

27-04-2026

Benchmark Financial Wealth Advisors, LLC filed its 13F-HR report disclosing $361,104,529 in equity holdings across 133 positions as of March 31, 2026. The portfolio features heavy ETF exposure including Schwab Strategic TR Intl Eqty ETF at $26,507,039, Vanguard Index Fds Total Stk Mkt at $25,675,624, and DoubleLine ETF Trust Opportunistic Co at $23,917,289, alongside notable individual stocks like NVIDIA Corporation at $11,541,108. No period-over-period changes are detailed in this snapshot filing.

• ·Filing date: April 27, 2026
• ·Report period end: March 31, 2026
• ·Business address: 2351 NW Boca Raton Blvd, Suite 100, Boca Raton, FL 33431
• ·All holdings reported as sole investment discretion

27-04-2026

Schaeffer Financial LLC disclosed $118,809,627 in total equity holdings across 25 positions in its 13F-HR filing as of March 31, 2026, filed on April 27, 2026. The portfolio is dominated by ETFs including iShares 1-5 Year Investment Grade Corporate Bond ETF ($34,130,973), Schwab U.S. Broad Market ETF ($22,649,659), and SPDR S&P 500 ETF ($19,020,262), with no reported changes or voting authority beyond sole discretion. Individual stock holdings remain modest, such as Exxon Mobil Corp ($1,081,757) and Microsoft Corp ($867,840).

• ·Filing covers period ending 03-31-2026 with no voting authority or performance data reported
• ·SEC file number: 028-21634; CIK: 0001898838
• ·Additional holdings include Caterpillar Inc ($324,039), Home Depot Inc ($242,063), JPMorgan Chase & Co ($234,740)

27-04-2026

Consolidated Portfolio Review Corp filed its 13F-HR report on April 27, 2026, disclosing $1,095,649,184 in total portfolio value across 34 holdings as of March 31, 2026. The portfolio is heavily concentrated in the Vanguard Total Stock Market ETF at $922,908,769, with significant exposure to Bitcoin ETFs including iShares Bitcoin Trust ($82,302,748) and Fidelity Wise Origin Bitcoin ($49,252,684). Other positions include broad market ETFs, tech stocks like Alphabet and Amazon, and smaller stakes in names like Berkshire Hathaway Class A.

• ·All holdings reported with sole voting and disposition power (SH SOLE).
• ·Smallest notable position: Berkshire Hathaway Class A (5 shares, $3,590,700).
• ·Atlas Energy Solutions Inc: 627,945 shares, $8,238,638.

27-04-2026

CWS Financial Advisors, LLC filed its 13F-HR report for the period ended March 31, 2026, disclosing a diversified portfolio of 157 securities with a total value of $390,266,581,000. Top holdings include Stryker Corporation at $79,905,217,000 (243,176 shares), Dimensional ETF Trust US Equity Market ETF at $31,422,753,000 (443,136 shares), Vanguard Index FDS S&P 500 ETF at $24,786,590,000 (41,480 shares), Apple Inc at $15,366,973,000 (60,550 shares), and iShares TR Core S&P SCP ETF at $18,129,556,000 (145,841 shares). The portfolio emphasizes ETFs from Vanguard, Dimensional, and iShares alongside blue-chip stocks like Microsoft ($6,738,364,000; 18,203 shares) and Amazon ($1,420,193,000; 6,819 shares), with all positions held under sole discretion.

• ·All holdings reported with sole investment and voting authority (0 shared, 0 none)
• ·No put/call positions
• ·Portfolio period end date: March 31, 2026
• ·Filing signed April 17, 2026 in Kalamazoo, MI

27-04-2026

Geremia Financial Services, LLC filed its 13F-HR on April 27, 2026, for the quarter ended March 31, 2026, disclosing $122,776,941 in total 13F securities across 10 positions, all held with sole voting authority. The largest holding is NVIDIA with 231,287 shares valued at $40,336,453, followed by Goldman Sachs Group Inc at $12,798,137 (15,128 shares) and Apple Inc at $10,047,546 (39,590 shares). No additions or deletions were reported during the period.

• ·All positions reported with sole voting authority and no reported additions or deletions.
• ·Firm address: 1090 King Georges Post Road, Suite 801, Edison, NJ 08837.
• ·Central Index Key: 0002104898.

27-04-2026

Carter Financial Group, INC. filed its 13F-HR report disclosing total equity holdings valued at $161665299 across 126 positions as of March 31, 2026, with sole discretionary voting power over all reported shares. Top holdings include Berkshire Hathaway Inc Class B (19987259 market value), Apple Inc (6474607), and NVIDIA Corp (4940108). The portfolio is diversified across individual stocks and ETFs, with no shared voting authority reported.

• ·Filing submitted on April 27, 2026, for period ending March 31, 2026
• ·All holdings reported as SH SOLE with zero other voting powers

27-04-2026

Cincinnati Financial Corp (CINF) reported net income of $274 million for the three months ended March 31, 2026, swinging from a $90 million loss in the prior-year period, fueled by earned premiums growth of 11% to $2,604 million, investment income up 14% to $318 million, and lower insurance losses of $1,751 million. Total revenues rose 12% to $2,863 million, with diluted EPS of $1.75 versus $(0.57). However, net investment losses widened slightly to $70 million from $67 million, comprehensive income fell to $123 million due to a $151 million OCI loss from unrealized investment declines, and shareholders' equity decreased to $15,714 million from $15,911 million at December 31, 2025.

• ·Share repurchases under authorization: $179 million and 1.1 million shares in Q1 2026 vs $42 million and 0.3 million shares in Q1 2025.
• ·Dividends declared: $145 million or $0.94 per share in Q1 2026 vs $135 million or $0.87 per share in Q1 2025.
• ·Gross loss reserves increased to $11,884 million at March 31, 2026 from $11,450 million at start of period.

27-04-2026

Definium Therapeutics, Inc. filed DEFA14A additional proxy materials for its 2026 Annual General and Special Meeting on June 11, 2026, proposing the election of seven director nominees (Robert Barrow, Suzanne Bruhn Ph.D., Roger Crystal M.D., David Gryska, Andreas Krebs, Carol A. Vallone, and Roger Adsett), appointment of KPMG LLP as independent auditor until 2027, and approval of an amendment to increase common shares available under the 2025 Equity Incentive Plan by 5,000,000 shares. The board recommends voting 'For' all proposals. Shareholders must vote by June 10, 2026, 11:59 PM ET, with materials available at www.ProxyVote.com.

• ·Meeting held virtually at www.virtualshareholdermeeting.com/DFTX2026 on June 11, 2026, at 10:00 A.M. Eastern Time
• ·Proxy materials request deadline: May 28, 2026
• ·Control numbers referenced for voting: V93765-P52037, V93766-P52037

27-04-2026

Abbott Laboratories amended and restated its By-Laws, effective April 24, 2026, originally adopted in 1963. The updated By-Laws specify the principal office location in Lake County, Illinois, and outline procedures for annual shareholder meetings, including election of directors and transaction of business. They impose detailed and stringent requirements for shareholder nominations and proposals, mandating timely written notices 90-120 days prior to the anniversary of the prior annual meeting, with updates and supplements as needed.

• ·Principal office: intersection of State Routes 43 and 137, Lake County, Illinois.
• ·Shareholder notice timeliness: not later than 90th day nor earlier than 120th day prior to prior annual meeting anniversary; adjusted if meeting date shifts by more than 30-60 days.
• ·Notice updates required as of record date and 10 business days prior to meeting.
• ·References Exchange Act rules including Rule 14a-8, Schedule 13D, 13F, 13G.

27-04-2026

Columbia Financial, Inc. entered into new two-year employment agreements effective April 1, 2026, with five senior executives—Dennis E. Gibney, Allyson Schlesinger, John Klimowich, Oliver E. Lewis, Jr., and Manesh Prabhu—replacing prior agreements and including annual base salaries for 2026 ranging from $430,000 to $700,000, eligibility for incentive plans, equity awards, and fringe benefits. The agreements feature automatic annual extensions unless notice is given 60 days prior, post-employment restrictive covenants, and severance provisions including 2x (base salary + target bonus) for termination without cause, escalating to 3x upon a change in control. No performance declines or negative metrics are reported in this governance-focused filing.

• ·Agreements entered into on April 21-22, 2026; initial term two years with auto-extension by 12 months each April 1 starting 2027 unless 60-day notice.
• ·Severance for termination without cause: 2x (base salary + target bonus); for disability/death: 1x (base salary + target bonus).
• ·Change in control severance within 24 months: 3x (base salary + target bonus) plus prior year bonus and 36 months health coverage subsidy.
• ·Restrictive covenants: 24-month non-solicitation/non-competition, perpetual confidentiality, mutual non-disparagement.

27-04-2026

On April 27, 2026, Waterstone Financial, Inc. (WSBF) announced that its Board of Directors authorized the repurchase of up to an additional 2,000,000 shares of the Company's outstanding common stock under its existing repurchase program. Following this authorization, a total of 2,148,285 shares are now available for repurchase. The announcement was made via a press release filed as Exhibit 99.1.

27-04-2026

Beacon Financial Advisory LLC filed its 13F-HR on April 27, 2026, reporting 402 equity positions held as of March 31, 2026, with all holdings under sole voting authority and no changes or shared voting noted. The portfolio is diversified across individual stocks and ETFs, with top holdings including Apple Inc ($9,106,253 value, 35,881 shares) and Amazon.com Inc ($5,458,757 value, 26,210 shares). No period-over-period comparisons are available in this filing.

• ·All 402 positions reported as SOLE voting authority with 0 shared or none
• ·Business address: 25825 Science Park Drive Suite 110, Cleveland, OH 44122
• ·Phone: 216-910-1865
• ·SEC file number: 028-19683

27-04-2026

Vertex, Inc. (VERX) has issued definitive additional proxy materials (DEFA14A) for its Annual Meeting of Stockholders on June 10, 2026, at 9:00 a.m. EDT, held virtually. The meeting includes proposals for the election of three directors—Eric Andersen, David DeStefano, and Christopher Young—and ratification of Crowe LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with the Board recommending a FOR vote on both. Proxy materials are available online at www.proxydocs.com/verx, and stockholders must register to attend and vote.

• ·Filing date: April 27, 2026
• ·Request paper copies by May 29, 2026 for timely delivery
• ·Virtual meeting registration at www.proxydocs.com/verx using control number
• ·Online voting at www.proxypush.com/verx

27-04-2026

The Cigna Group held its Annual Meeting of Shareholders on April 22, 2026, with 237,225,441 shares (89.97% of 263,660,761 outstanding) represented. All twelve director nominees were elected with strong majorities (ranging from approximately 94% to 98% For), executive compensation received advisory approval (201,746,941 For vs. 17,359,954 Against), and PricewaterhouseCoopers LLP was ratified as auditors (216,061,458 For). A shareholder proposal for the right to act by written consent failed (104,982,574 For vs. 114,173,793 Against).

• ·Broker non-votes: 17,604,610 across Proposals 1, 2, and 4
• ·Proxy Statement filed March 13, 2026

27-04-2026

Mustard Seed Financial, LLC filed its 13F-HR on April 27, 2026, disclosing $166876423 in total holdings value across 92 positions as of March 31, 2026, all held with sole voting power and no other rights. The portfolio features significant allocations to fixed income ETFs like Vanguard Short Term Bond ETF (16013919 value) and Intermediate Term Bond ETF (10270210 value), alongside equity ETFs from Dimensional and stocks including NVIDIA Corporation (3953000 value). No period-over-period changes are provided in the filing.

• ·Filing period end date: March 31, 2026
• ·All 92 positions reported as SH SOLE with 0 shared voting or disposition power
• ·Heavy concentration in Dimensional ETFs (e.g., US Large Cap Value: 222848 shares; Intl Core Equity: 168266 shares) and Vanguard bond ETFs
• ·Notable stock holdings include Apple Inc. (8123 shares), Walmart Inc. (41310 shares), Exxon Mobil Corp (17465 shares)

27-04-2026

FB Financial Corporation renewed its stock repurchase plan, authorizing the repurchase of up to $175,000,000 of its common stock, par value $1.00 per share, with the plan terminating on June 30, 2027 or upon reaching the maximum amount. The repurchases will comply with Rule 10b-18 under the Exchange Act and may be suspended or discontinued at any time. The company also issued a press release on April 27, 2026, furnished as Exhibit 99.1.

• ·Event reported date: April 21, 2026
• ·Filing date: April 27, 2026

27-04-2026

Capital Financial Group Inc./ADV filed its 13F-HR report on April 27, 2026, disclosing 106 equity positions totaling $182,042,299 as of March 31, 2026. The portfolio features a mix of individual stocks and ETFs, with the largest holdings being Goldman Sachs ActiveBeta International Equity ETF ($12,653,988), iShares MSCI USA Min Vol Factor ETF ($12,176,115), and SPDR S&P 500 ETF Trust ($5,976,638). The report was signed by Leah Hlewko, Chief Compliance Officer.

• ·Business address: 13986 Bowles Ave., Suite 200, Littleton, CO 80127
• ·Phone: 303-629-7500
• ·SEC file number: 028-26406
• ·Investment adviser CRD: 801-117272

27-04-2026

TCI Wealth Advisors, Inc. disclosed a portfolio of 251 equity positions totaling $1,883,313,234 as of March 31, 2026, in its quarterly 13F-HR filing. Holdings are heavily weighted toward Dimensional ETF Trust products (e.g., US Equity Market ETF at $235,522,772), American Century ETFs, Vanguard funds, and individual large-cap stocks like Apple Inc. ($31,673,598) and Microsoft Corp. ($11,285,234). No prior period comparisons or changes in holdings are provided in this snapshot report.

• ·Filing date: April 27, 2026
• ·Report period end: March 31, 2026
• ·Business address: 4011 E Sunrise Dr, Tucson, AZ 85718
• ·All positions held with sole voting power (SH SOLE)

27-04-2026

Tradewinds Universal, a Wyoming-incorporated holding company focused on food and manufacturing (formerly Tradewinds Enterprises, Inc.), filed an S-1/A amendment on April 27, 2026, registering up to 20,000,000 shares of common stock for resale by RH2 Equity Partners under a January 29, 2026 Common Stock Purchase Agreement. The company will not receive proceeds from resales but may receive up to $10,000,000 from future discretionary share sales to RH2 post-effectiveness. TRWD common stock trades on OTCMarkets at a last reported closing price of $0.0525 per share on April 20, 2026, with no period-over-period financial performance data disclosed in this filing.

• ·Incorporated December 28, 2021 in Wyoming; name change from Tradewinds Enterprises, Inc. on March 10, 2022.
• ·Business address: 501 Mercury Lane, Brea, CA 92821.
• ·Fiscal year end: December 31.
• ·SIC: Food & Kindred Products [2000].
• ·SEC file number: 333-276233; original S-1 filed April 14, 2026.

27-04-2026

Lifeward Ltd. (LFWD) filed an S-3 registration statement on April 27, 2026, registering 7,256,474 ordinary shares for resale by selling shareholders, including shares issuable upon exercise of warrants and conversion of notes. The company will not receive proceeds from these resales but may receive funds from cash exercises of certain warrants for general corporate purposes. As of April 24, 2026, 2,778,585 ordinary shares were issued and outstanding out of 100,000,000 authorized.

• ·Quorum for general meetings: at least two shareholders holding 33 1/3% of voting rights.
• ·Board of directors: 5-13 members, including two external directors as required by Israel Companies Law.
• ·Selling shareholders bear their own selling expenses; company bears registration costs.

27-04-2026

Pfizer Inc. held its Annual Meeting of Shareholders on April 23, 2026, where all 12 director nominees were elected with strong majorities, ranging from 2,929,511,380 votes for Joseph J. Echevarria to 3,468,177,423 for Cyrus Taraporevala, against votes under 613 million each. Management proposals passed decisively, including ratification of KPMG LLP as auditors (4,160,827,231 for vs. 321,979,096 against), approval of the amended Pfizer Inc. 2019 Stock Plan (3,227,692,578 for), and advisory approval of 2026 Named Executive Officer compensation (3,099,249,442 for). However, the shareholder proposal to adopt an Independent Chair policy failed with 1,015,206,372 votes for versus 2,509,042,021 against.

• ·Proxy Statement filed with SEC on March 12, 2026
• ·All director elections had identical broker non-votes of 941,392,137
• ·KPMG LLP ratification had no broker non-votes

27-04-2026

Able View Global Inc. reported total assets of $34,550,271 as of December 31, 2025, down 27.7% from $47,630,015 in 2024, primarily due to sharp declines in cash (-40.7% to $9,010,336) and assets from discontinued operations, offset somewhat by a surge in prepayments and other current assets (up 256% to $6,987,633). Total liabilities decreased 34.0% to $26,778,062 from $40,538,800, driven by a $11.1 million net settlement of dividends payable (now $4,629,034, extended to July 2027) and elimination of discontinued operations liabilities; however, current liabilities rose 13.5% to $19,771,916 amid higher short-term loans ($9,259,172, up 16.1%).

• ·Loans to Shanghai Jingyue of $1,212,614 bear 3% interest, repayable December 30, 2026.
• ·Prepayment of $1,005,942 reclassified to due from supplier after termination; $800,000 collected as of report date.
• ·Dividends payable of $4,629,034 extended to July 2027.
• ·Year ended Dec 31, 2025 borrowings: $5.4M from financial institutions (repaid), $21.1M + $0.7M + $4.9M renewed from banks; repayments $2.5M + $23.4M.

27-04-2026

IRON Financial LLC filed its 13F-HR on April 27, 2026, disclosing $228,836,757 in total 13F securities value as of March 31, 2026, across 217 positions primarily consisting of ETFs and individual stocks. Key holdings include Hartford FDS Exchange Traded Total Rtrn ETF at $8,305,132, iShares TR Core 1-5 Yr USD at $16,019,542, CME Group Inc at $17,215,742, and Apple Inc at $15,751,969. No prior period data is provided for comparison.

• ·Filing CIK: 0001595509
• ·Filer address: 630 Dundee Road, Suite 300, Northbrook, IL 60062
• ·SEC file number: 028-15674
• ·Adviser CRD: 106682

27-04-2026

Core Scientific, Inc. announced a multi-tiered strategy to scale its Pecos, Texas campus to approximately 1.5 GW of gross power, or approximately 1.0 GW of leasable power, via a press release issued on March 27, 2026, and furnished in this 8-K filing on April 27, 2026. No prior period data or financial metrics were provided in the disclosure.

• ·Press release attached as Exhibit 99.1
• ·Securities registered: Common stock (CORZ, par value $0.00001), Warrants (CORZW, CORZZ) on Nasdaq Global Select Market
• ·Furnished under Regulation FD Disclosure (Item 7.01); not deemed 'filed'